Anaphylaxis to the 23-valent pneumococcal vaccine: A second explored case by means of immediate-reading skin tests with pneumococcal vaccines

Vaccine

Volumn 28, Issue 52, 2010, Pages 8256-8257

  Ponvert, C ^a   Scheinmann, P ^a   de Blic, J ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Allergy; Anaphylaxis; Child; Pneumococcal vaccines; Skin tests

Indexed keywords

ADRENALIN; BRONCHODILATING AGENT; CORTICOSTEROID; IMMUNOGLOBULIN E; PNEUMOCOCCUS VACCINE;

ANAPHYLAXIS; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SKIN TEST;

ANAPHYLAXIS; ANTIBODIES, BACTERIAL; CHILD; FEMALE; HUMANS; IMMUNOGLOBULIN E; PNEUMOCOCCAL VACCINES; SKIN TESTS;

EID: 78649720921     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.10.031     Document Type: Article

References (18)

1. SAMA-SA Pulmonology Society Working Group Adult pneumococcal vaccination guidelines. S Afr Med J 1999, 89:1222-1230.
2. Holdiness M.R. Rare systemic dermatologic reaction after pneumococcal vaccine administration. South Med J 2003, 96:64-65.
3. Nichol K.L., Mac Donald R., Hauge M. Side effects associated with pneumococcal vaccination. Am J Infect Control 1997, 25:223-228.
4. Nikkels A.F., Nikkels-Tassoudji N., Piérard G.E. Cutaneous adverse reactions following anti-infective vaccinations. Am J Clin Dermatol 2005, 6:79-87.
5. Wise R.P., Iskander J., Douglas-Pratt R., Campbell S., Ball R., Pless R.P., et al. Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine. J Am Med Assoc 2004, 292:1702-1710.
6. Yousef E., Mannan S. Systemic reaction to pneumococcal vaccine: how common in pediatrics?. Allergy Asthma Proc 2008, 29:397-399.
7. Ponvert C., Ardelean-Jaby D., Colin-Gorski A.M., Soufflet B., Hamberger C., de Blic J., et al. Anaphylaxis to the 23-valent pneumococcal vaccine in child: a case-control study based on immediate responses in skin tests and specific IgE determination. Vaccine 2001, 19:4588-4591.
8. Brockow K., Romano A., Blanca M., Ring J., Pichler W., Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002, 57:45-51.
9. Jin C., Hantusch B., Hemmer W., Stadlmann J., Altmann F. Affinity of IgE and IgG against cross-reactive carbohydrate determinants on plant and insect glycoproteins. J Allergy Clin Immunol 2008, 121:185-190.
10. Mari A. IgE to cross-reactive carbohydrate determinants: analysis of the distribution and appraisal of the in vivo and in vitro reactivity. Int Arch Allergy Immunol 2002, 129:286-295.
11. Hemmer W., Focke M., Kolarich D., Wilson I.B., Altmann F., Wöhrl S., et al. Antibody binding to venom carbohydrates is a frequent cause for double positivity to honeybee and yellow jacket venom in patients with stinging-insect allergy. J Allergy Clin Immunol 2001, 108:1045-1052.
12. Commins S.P., Platts-Mills T.A.E. Allergenicity of carbohydrates and their role in anaphylactic events. Curr Allergy Asthma Rep 2010, 10:29-33.
13. Abuaf N., Rostane H., Rajoely B., Gouar H., Autegarden J.E., Leynadier F., et al. Comparison of two basophil activation markars CD63 and CD203c in the diagnosis of amoxicillin allergy. Clin Exp Allergy 2008, 3:921-928.
14. Gamboa P.M., Garcia-Avilés M.C., Urrutia I., Antépara I., Esparza R., Sanz M.L. Basophil activation and sulphidoleukotriene production in patients with immediate allergy to betalactams and negative skin tests. J Invest Allergol Clin Immunol 2004, 14:278-283.
15. Haussmann O.V., Gentinetta T., Bridts C.H., Ebo D.G. The basophil activation test in immediate-type drug allergy. Immunol Allergy Clin North Am 2009, 29:555-566.
16. Sanz M.L., Gamboa P.M., Mayorga C. Basophil activation tests in the evaluation of immediate drug hypersensitivity. Curr Opin Allergy Clin Immunol 2009, 9:298-304.
17. Oswalt M.L., Kemp S.F. Anaphylaxis: office management and prevention. Immunol Allergy Clin North Am 2007, 27:177-191.
18. Simons F.E.R., Anaphylaxis J Allergy Clin Immunol 2010, 125:S161-S181.